Instil Bio (TIL) Long-Term Debt Issuances (2022 - 2024)
Instil Bio (TIL) posted quarterly Long-Term Debt Issuances of $85.6 million for Q4 2024, up 1087.43% year-over-year from $7.2 million in Q1 2024, and up 1087.43% quarter-over-quarter from -$8.7 million in Q4 2023.
Instil Bio (TIL) Long-Term Debt Issuances (2022 - 2024) Analysis & Trends
Instil Bio's Long-Term Debt Issuances history runs 3 years deep, the most recent figure standing at $85.6 million for Q4 2024.
- In Q4 2024, Long-Term Debt Issuances rose 1087.43% year-over-year to $85.6 million; the TTM figure through Dec 2024 stood at $85.6 million (changed N/A YoY), while the FY2024 annual figure was $85.6 million, changed N/A from the prior year.
- Long-Term Debt Issuances for Q4 2024 stood at $85.6 million, up from -$8.7 million in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $85.6 million in Q4 2024, with the low at -$64.5 million in Q4 2022.
- The 3-year median for Long-Term Debt Issuances is $4.5 million (2023), against an average of $12.2 million.
- The sharpest annual moves came in 2023 and 2024: Long-Term Debt Issuances slumped 91.61% in 2023, then soared 1087.43% in 2024.
- Instil Bio's Long-Term Debt Issuances stood at -$64.5 million in 2022, then jumped by 86.56% to -$8.7 million in 2023, then jumped by 1087.43% to $85.6 million in 2024.
- Business Quant data shows TIL's Long-Term Debt Issuances at $85.6 million in Q4 2024, -$8.7 million in Q4 2023, and $4.2 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Instil Bio | 51.68 Mn | 51.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 85.60 Mn |
| Dec 31, 2024 | 85.60 Mn |
| Dec 31, 2023 | -8.67 Mn |
| Dec 31, 2023 | -8.67 Mn |
| Jun 30, 2023 | 4.20 Mn |
| Jun 30, 2023 | 4.20 Mn |
| Mar 31, 2023 | 4.47 Mn |
| Mar 31, 2023 | 4.47 Mn |
| Dec 31, 2022 | -64.51 Mn |
| Dec 31, 2022 | -64.51 Mn |
| Sep 30, 2022 | 14.45 Mn |
| Sep 30, 2022 | 14.45 Mn |
| Jun 30, 2022 | 50.06 Mn |
| Jun 30, 2022 | 50.06 Mn |